Nutraceutix Licenses Subsidiary Of Boehringer-ingelheim To Market Calcium D-glucarate

Nutraceutix, Inc. has licensed Quest Vitamins, a subsidiary of Boehringer-Ingelheim, (Canada) Ltd. the non-exclusive right to distribute health supplement products containing the patented dietary supplement compound, Calcium D-Glucarate(TM). Boehringer Ingelheim group, is one of the world’s 20 leading pharmaceutical corporations — with products focused on human pharmaceuticals (prescription, hospital and self-medication) as well as animal Read more about Nutraceutix Licenses Subsidiary Of Boehringer-ingelheim To Market Calcium D-glucarate[…]

Phase-1 Molecular Toxicology To Develop Diagnostic Technologies

Phase-1 Molecular Toxicology Inc. has announced a large collaborative research agreement with Boehringer Ingelheim Pharmaceuticals Inc. to develop diagnostic technologies to identify which patients will suffer from adverse reactions to drugs prior to treatment. Spencer Farr, Ph.D. CEO of Phase-1 had this to say about the collaboration with Boehringer Ingelheim Pharmaceuticals: “We believe that this Read more about Phase-1 Molecular Toxicology To Develop Diagnostic Technologies[…]